JS

Jayanta Sarakar

Active Director Director DIN 08545909
DIN 08545909 First appointment Aug 2019 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2019
Shareholding value •••• Premium profile

About Jayanta Sarakar

Data last updated:

Jayanta Sarakar is a Director at Boneym Pharmaceuticals Private Limited (since 2019). The company operates in Trading. Boneym Pharmaceuticals Private Limited reported revenue of ₹36 Lakh (FY 2025).

DIN 08545909
Primary Designation Director
Industry Trading
First Appointment 22 Aug 2019
Oldest Company Age 8 yrs
Largest company Boneym Pharmaceuticals Private Limited · ₹36 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Aug 20192018₹36 Lakh (FY 2025)Active

Board colleagues of Jayanta Sarakar

NameDINCompanyDesignation
Manoj Kumar Shah09675220Boneym Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Boneym Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jayanta Sarakar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jayanta Sarakar

Jayanta Sarakar currently holds 1 directorship: Boneym Pharmaceuticals Private Limited (Director, since 22 Aug 2019, revenue ₹36 Lakh (FY 2025)).

Jayanta Sarakar was first appointed on 22 Aug 2019 as Director at Boneym Pharmaceuticals Private Limited.

The current boards of Jayanta Sarakar's companies include Manoj Kumar Shah (Boneym Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available